Continuous Cardiac Monitoring.
Anytime, Anywhere.

Corsano Health B.V. is a health-tech company developing, producing and marketing medically certified continuous health monitoring devices. The Corsano brandname is derived from in corpore sano (in a healthy body).

Its first product, the Corsano CardioWatch is an essential part of a cardiac arrhythmia screening system that can, by providing a simple and effective method for continuous monitoring of the user’s heart rhythm, help identify the risk of a heart attack in an early stage. In its most extended version, the system consists of a bracelet plus a dedicated app on the user’s smartphone. The system can assist the user with maintaining a healthy lifestyle by providing immediate feedback on activity, sleep and heart rhythm data. Furthermore, smart analytics produce relevant data for timely detection of heart rhythm anomalies.

Corsano Health B.V. is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards.

Validated Data

Clinical evidence for multiple use cases. ISO13485 and EU-MDR certified

Clinic-focused

 Built in close collaboration with clinical professionals. 

Flexibility to develop custom solutions

Patient friendly

Battery life 8-15 days.
Ergonomic and aesthetic designs that stimulate continuous wear

Security & Privacy

Secure and Private Health Cloud, GDPR, Anonymization

EU-MDR CE Certified

The CardioWatch 287 is a medically certified wireless remote monitoring system intended for continuous collection of physiological data in home and healthcare settings. CardioWatch 287-1 is a CE medical device certified under EU-MDR standards. This includes heart rate, heart rate variability (R-R interval), respiration rate, activity and sleep. Data is transmitted wirelessly from the device via the application or gateway to a health cloud where it is stored and made available for further analysis.

The CardioWatch 287 can include the ability to notify healthcare professionals when physiological data fall outside selected parameters.

The high-quality patented PPG interface enables the device to accurately measure the following vital parameters:

  • Sleep (validated PPG-Based Sleep Staging – Jul. 2017)
  • A-Fib (CE Class IIa Certified algorithm Preventicus – May 2018)
  • Activity Type, Speed, Cadence (validated VSO ELAN – Nov. 2019)
  • Heart Rate (Validated CCN – Mar. 2021)
  • RR intervals (Validated CCN – Mar. 2021)
  • Respiration Rate (Haaglanden Clinics – Jun. 2021)
  • SPO2 (in development – Dec. 2021)
  • Core Body Temperature (in development – Oct. 2021)
  • Blood Pressure (in development Reinier de Graaf – Dec. 2021)

 

Addressable Markets

Sector

Diagnostic & remote medical monitoring 

Digital mental health & wellness

Contract Research Organizations

Applications

Hospital & ambulant patient monitoring

Remote monitoring & care, digital therapeutics, corporate well-being

Decentralized clinical trials for active pharmaceutical ingredients

Partners

Corsano has made “Cooperation” one of the core values upon which the company commits to base all its relationships. To be successful in business and life, a relationship has to be a two way street with give and take. At Corsano, we believe in cultivating good working relationships with our partners. We don’t limit ourselves to a select few, but always attempt to find the best possible partners. Corsano develops and manufactures medical wearables for research and continuous patient monitoring, that is our core business. Our open strategy is to connect to partner platforms and systems via APIs. We provide access to raw and processed data to partners enabling them to offer a variety of healthcare services. As such, we deal with hospitals, CROs, associations and companies worldwide

Translate